Kidney cancer: The new landscape

Current Opinion in Urology

Volumn 19, Issue 2, 2009, Pages 133-137

  Linehan, Jennifer A ^a   Nguyen, Mike M ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Diagnosis; Epidemiology; Kidney; Kidney neoplasms

Indexed keywords

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CRYOTHERAPY; HUMAN; INCIDENTAL FINDING; KIDNEY CANCER; KIDNEY FUNCTION; NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TUMOR VOLUME;

AGE FACTORS; EUROPE; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; KIDNEY NEOPLASMS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 61349164864     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328323f5ab     Document Type: Review

References (23)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
2. Lang K, Danchenko N, Gondek K, et al. The burden of illness associated with renal cell carcinoma in the United States. Urol Oncol 2007; 25:368-375.
3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98:1331-1334.
4. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281:1628-1631.
5. Adams KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 2008; 168:268-277. By demonstrating the association of obesity to renal cancer incidence, this research improves our understanding of underlying factors that are leading to the increased incidence of renal cancer seen in the majority of countries.
6. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008; 101:949-958. The above article provides an overview of renal cancer incidence and mortality trends in the European Union, highlighting differences between countries. These differences suggest that there may be a role for population-based changes to decrease risk of renal cancer.
7. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 2000; 56:58-62.
8. Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival. Scand J Urol Nephrol 2002; 36:414-418.
9. Schlomer B, Figenshau RS, Van Y, et al. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 2006; 176 (4 Pt 1): 1317-1320; discussion 1320.
10. Smith SJ, Bosniak MA, Megibow AJ, et al. Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989; 170 (3 Pt 1):699-703.
11. Levin DC, Rao VM, Parker L, et al. Recent trends in utilization rates of abdominal imaging: the relative roles of radiologists and nonradiologist physicians. J Am Coll Radiol 2008; 5:744-747. The above article provides insight into changes in imaging utilization using Medicare data. Use of abdominal imaging has played the primary role in the increase in incidentally diagnosed renal cancers.
12. Tsui KH, Shvarts O, Smith RB, et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000; 163:426-430.
13. Cooperberg MR, Mallin K, Ritchey J, et al. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol 2008; 179:2131-2135.
14. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 2006; 176 (6 Pt 1):2397-2400; discussion 2400.
15. Woldrich JM, Mallin K, Ritchey J, et al. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J Urol 2008; 179:1709-1713; discussion 1713.
16. Nguyen MM, Gill IS. Effect of renal cancer tumor size on the prevalence of metastasis at diagnosis and mortality. J Urol 2009 (in press).
17. Verhoest G, Veillard D, Guille F, et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol 2007; 51:1298-1304; discussion 1304-1295.
18. Skolarus TA, Serrano MF, Berger DA, et al. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 2008; 179:439-443; discussion 443-434.
19. Abou Youssif T, Kassouf W, Steinberg J, et al. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 2007; 110:1010-1014. The above is one of several active surveillance series reported. Of particular interest because of the documentation of two cases of progression to metastasis, including the interval increase in tumor size that was associated with progression.
20. Crispen PL, Viterbo R, Fox EB, et al. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 2008; 112:1051-1057.
21. Kouba E, Smith A, McRackan D, et al. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 2007; 177:466-470; discussion 470.
22. Siu W, Hafez KS, Johnston WK 3rd, Wolf JS Jr. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol 2007; 25:115-119.
23. Klatte T, Patard JJ, Goel RH, et al. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol 2007; 178:35-40; discussion 40.